Showing results (111-120 of 4,635) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|September 27, 2006
RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patientsRudolf Fahrig, Detlef Quietzsch, Jörg-Christian Heinrich, et al.Anti-Cancer Drugs|September 27, 2006
A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancerThierry Delozier, Jean-Paul Guastalla, Alejandro Yovine, et al.Anti-Cancer Drugs|September 27, 2006
Dose-escalated abarelix in androgen-independent prostate cancer: a phase I studyTomasz M Beer, Christopher Ryan, Gajanan Bhat, et al.Anti-Cancer Drugs|September 27, 2006
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancerLorenzo Livi, Fabiola Paiar, Roberto Santini, et al.Anti-Cancer Drugs|June 22, 2007
Establishment of in-vitro models of chemotherapy resistanceMark B Watson, Michael J Lind, Lynn CawkwellAnti-Cancer Drugs|June 22, 2007
Estrogen-dependent regulation of Eg5 in breast cancer cellsMaricarmen D Planas-Silva, Irina S FilatovaAnti-Cancer Drugs|August 21, 2007
Structure-antileukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a comparative studyManolis A Fousteris, Anna I Koutsourea, Evagelia S Arsenou, et al.Anti-Cancer Drugs|August 21, 2007
Synthesis of 1,1,2-triphenylethylenes and their antiproliferative effect on human cancer cell linesLifang Zheng, Qingyi Wei, Bo Zhou, et al.Anti-Cancer Drugs|August 21, 2007
Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoproteinLibin Huang, Chunhui Wang, Wenbin Zheng, et al.Anti-Cancer Drugs|August 21, 2007
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in miceLuca Santucci, Andrea Mencarelli, Barbara Renga, et al.Pageof 464